Immunovant, Inc.
USD30.92
-1.94 (-5.90%)
CEO
Eric Venker
IPO Date
2019-06-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$32.68
Prev. Close
$32.86
Day Low
$30.44
Day High
$32.70
52W Low
$14.32
52W High
$36.28
Market Cap
$6.35B
Volume
1.89M
| 71,492 |
| $7.94 |
| 29 May 2026 | Fromkin Andrew J. | director | M-Exempt | Acquired | 77,181 | $8.43 |
| 29 May 2026 | Fromkin Andrew J. | director | M-Exempt | Acquired | 16,260 | $14.70 |
| 29 May 2026 | Fromkin Andrew J. | director | S-Sale | Disposed | 11,483 | $32.64 |
| 29 May 2026 | Fromkin Andrew J. | director | S-Sale | Disposed | 210,468 | $33.56 |
| 29 May 2026 | Fromkin Andrew J. | director | M-Exempt | Disposed | 31,668 | $4.99 |
| 29 May 2026 | Fromkin Andrew J. | director | M-Exempt | Disposed | 71,492 | $7.94 |
| 29 May 2026 | Fromkin Andrew J. | director | M-Exempt | Disposed | 77,181 | $8.43 |
| 29 May 2026 | Fromkin Andrew J. | director | M-Exempt | Disposed | 16,260 | $14.70 |